- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial2018 | Publication without faculty affiliation
- Primary hyperparathyroidism with severe osteoporosis - relapse following five-year complete remission2016 | Faculty of Medicine in Pilsen
- Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial2018 | First Faculty of Medicine
- Possibilities and limits of treatment of osteoporosis2009 | First Faculty of Medicine
- Progress in search for new osteoporosis therapies2014 | First Faculty of Medicine
- Efficacy of teriparatide compared with risedronate on FRAX(R)-defined major osteoporotic fractures: results of the VERO clinical trial2020 | First Faculty of Medicine
- Growth hormone and bone2011 | Faculty of Medicine in Hradec Králové
- Characteristics of Hajdu-Cheney syndrome and specifics of the full denture: case report2010 | First Faculty of Medicine, Second Faculty of Medicine
- Pharmacological treatment of postmenopausal and involution osteoporosis2015 | First Faculty of Medicine
- Causes of Changes in the Spectrum of Acetabular Fractures in the Last 20 Years2020 | Faculty of Medicine in Pilsen, Third Faculty of Medicine